Skip to main content
Livermore
Livermore
ZHEN

DnB Asset Management AS

SEC CIK
0001456670
Latest filing
Aug 11, 2026

FOLD holding history

Amicus Therapeutics, Inc. in every 13F filed by DnB Asset Management AS, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

FOLD overviewAll 13F holders of FOLDFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q2 2021
Holdings of FOLD by DnB Asset Management AS, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−14,662−100.0%Sold outHolders
Q1 202614,662$212.0K<0.1%+14,662NewHolders
Q4 20250$00.0%−46,161−100.0%Sold outHolders
Q3 202546,161$363.7K<0.1%+6,920+17.6%AddedHolders
Q2 202539,241$224.9K<0.1%+3,722+10.5%AddedHolders
Q1 202535,519$289.8K<0.1%+3,077+9.5%AddedHolders
Q4 202432,442$305.6K<0.1%−231−0.7%ReducedHolders
Q3 202432,673$348.9K<0.1%+490+1.5%AddedHolders
Q2 202432,183$318.9K<0.1%+5,165+19.1%AddedHolders
Q1 202427,018$317.7K<0.1%+2,182+8.8%AddedHolders
Q4 202324,836$352.4K<0.1%+550+2.3%AddedHolders
Q3 202324,286$295.1K<0.1%−5,903−19.6%ReducedHolders
Q2 202330,189$378.9K<0.1%+8,818+41.3%AddedHolders
Q1 202321,371$237.0K<0.1%+3,217+17.7%AddedHolders
Q4 202218,154$221.7K<0.1%−2,924−13.9%ReducedHolders
Q3 202221,078$220.1K<0.1%−4,617−18.0%ReducedHolders
Q2 202225,695$276.2K<0.1%+25,695NewHolders
Q1 20220$00.0%−22,837−100.0%Sold outHolders
Q4 202122,837$264.0K<0.1%−151,441−86.9%ReducedHolders
Q3 2021174,278$1.67M<0.1%+149,898+614.8%AddedHolders
Q2 202124,380$235.0K<0.1%+24,380NewHolders